Bladder Cancer
LightNews LightNews
banner
bladdercancer.bsky.social
Bladder Cancer
@bladdercancer.bsky.social
260 followers 69 following 1 posts
Resources for #BladderCancer research and information
Posts Replies Media Videos
Reposted by Bladder Cancer
yukselurun.bsky.social
In hematuria patients, urinary DNA methylation test showed 89% sensitivity & 88% specificity for high-grade/invasive #BladderCancer.
Outperformed NMP22 & cytology @oncoalert.bsky.social @jama.com
jamanetwork.com/journals/jam...
Urinary DNA Methylation Test for Bladder Cancer Diagnosis
This prospective multicenter study including individuals with hematuria evaluates the performance of a urinary DNA methylation test in identifying patients with high-grade or invasive bladder cancer.
jamanetwork.com
March 21, 2025 at 1:54 PM
Reposted by Bladder Cancer
cancercommunicator.com
#FDA approves neoadjuvant durvalumab w/ gem/cis followed by adjuvant durvalumab after radical cystectomy for MIBC based on NIAGRA study #oncsky #cansky #bladdercancer bit.ly/3DNZceK #blcsm
FDA approves durvalumab for muscle invasive bladder cancer
On March 28, 2025, the Food and Drug Administration approved durvalumab. Read more.
bit.ly
March 29, 2025 at 1:12 PM
Reposted by Bladder Cancer
nmurology.bsky.social
Zach Klaassen, MD, and @joshmeeks.bsky.social, MD, PhD, discuss the need to move beyond single-arm trials in BCG-unresponsive #BladderCancer treatment, given the current availability of multiple FDA-approved options.
bit.ly/44d1n6b
Moving Beyond Single Arm Trials in BCG Unresponsive Cancer Care - Joshua Meeks
Zachary Klaassen and Joshua Meeks discuss the need to move beyond single-arm trials in BCG-unresponsive bladder cancer treatment, given the current availability of multiple FDA-approved options. Dr. M...
bit.ly
April 3, 2025 at 12:53 PM
Reposted by Bladder Cancer
cancer-control.bsky.social
#Lebanon has one of the world’s highest #BladderCancer rates. New study reports 46% of cases are linked to smoking, 8.6% to contaminated water, and 6% to air pollution. Urgent action on tobacco control & environmental reform needed to reduce preventable cancer burden. #Oncology #MENAHealth
April 4, 2025 at 3:57 PM
Reposted by Bladder Cancer
abcuk.bsky.social
Join the University of Birmingham Bladder Cancer Research Centre and the Kings College London & Guys Hospital Transforming cancer OUtcomes through Research (TOUR) team at the Edgbaston Park Hotel & Conference Centre on Friday 28th February 2025.

#bladdercancer #cancerresearch
February 3, 2025 at 8:37 AM
Reposted by Bladder Cancer
oncodaily.bsky.social
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI - Andrea Necchi

oncodaily.com/science/213051

#BladderCancer #Cancer #Chemotherapy #Immunotherapy #MRI #OncoDaily #Oncology #Radiology #Medicine #Health
Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI - OncoDaily
Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI / Andrea
oncodaily.com
December 26, 2024 at 8:53 PM
Reposted by Bladder Cancer
ldelarica.bsky.social
New @theaacr.bsky.social Cancer Discovery paper on ecDNA in urothelial carcinoma reveals how ecDNAs:
💡 Drive #BladderCancer evolution
💡 Promote immune evasion
💡 Amplify oncogenes
💡 Fuel tumour heterogeneity
💡 May be a biomarker in urine for non-invasive detection
aacrjournals.org/cancerdiscov...
Spatial-Temporal Diversity of Extrachromosomal DNA Shapes Urothelial Carcinoma Evolution and Tumor-Immune Microenvironment
Abstract. Extrachromosomal DNA (ecDNA) presents a promising target for cancer therapy; however, its spatial-temporal diversity and influence on tumor evolution and the immune microenvironment remain l...
aacrjournals.org
March 11, 2025 at 2:39 PM
Reposted by Bladder Cancer
oncodaily.bsky.social
Rapid-fire debates bladder cancer at EAU 2025 - Gianluca Giannarini
@giannarini.bsky.social @uroweb.bsky.social

oncodaily.com/blog/gianluc...

#Cancer #Medicine #Health #BladderCancer #EAU25 #Oncology #OncoDaily
Gianluca Giannarini: Rapid-fire debates bladder cancer at EAU 2025 - OncoDaily
Gianluca Giannarini: Rapid-fire debates bladder cancer at EAU 2025 / bladder cancer, cancer, EAU 2025, Gianluca Giannarini, OncoDaily, Oncology, Shilpa Gupta
oncodaily.com
March 22, 2025 at 7:36 PM
Reposted by Bladder Cancer
oncodaily.bsky.social
Pros for BCG outlined by Gianluca Giannarini at EAU2025 - Sabine D. Brookman-May
@brookmans76.bsky.social @giannarini.bsky.social @uroweb.bsky.social

oncodaily.com/blog/sabine-...

#Cancer #Medicine #Health #EAU2025 #BladderCancer #Oncology #OncoDaily
Sabine D. Brookman-May: Pros for BCG outlined by Gianluca Giannarini at EAU2025 - OncoDaily
Sabine D. Brookman-May: Pros for BCG outlined by Gianluca Giannarini at EAU2025 / cancer, EAU2025, Gianluca Giannarini, Laura S. Mertens, OncoDaily, Oncology,
oncodaily.com
March 24, 2025 at 9:40 PM
Reposted by Bladder Cancer
achoud72.bsky.social
Looking for input from people with #bladdercancer Please answer the survey below if you can🙏🏽 @bladdercancer.bsky.social @mcrcnews.bsky.social
www.research.net/r/2025NewFaces
BCAN's 2025 New Faces of Bladder Cancer Survey
Take this survey powered by surveymonkey.com. Create your own surveys for free.
www.research.net
January 20, 2025 at 8:41 AM
Reposted by Bladder Cancer
jimcatto.bsky.social
Great to see this finally out #bladdercancer

ascopubs.org/doi/10.1200/...
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial
PURPOSETransurethral resection of bladder tumor (TURBT) is the initial staging procedure for new bladder cancers (BCs). For muscle-invasive bladder cancers (MIBCs), TURBT may delay definitive treatmen...
ascopubs.org
January 15, 2025 at 9:01 AM
Reposted by Bladder Cancer
jimcatto.bsky.social
Wow! Nanobots - powered by urea - target Bladder Cancer with radionucleotides

www.nature.com/articles/s41...
Urease-powered nanobots for radionuclide bladder cancer therapy - Nature Nanotechnology
Bladder cancer treatment suffers from low therapeutic efficacy. Here the authors present radioactive 131I-labelled urease-powered nanobots that exhibit enhanced accumulation at the tumour site, enabli...
www.nature.com
December 3, 2024 at 10:14 AM
Reposted by Bladder Cancer
jimcatto.bsky.social
Nice review on Metastatic non-muscle invasive bladder cancer. Great work www.nature.com/articles/s41... .....
Metastasis development in non-muscle-invasive bladder cancer - Nature Reviews Urology
In some instances (<5%), non-muscle-invasive bladder cancer can progress to metastatic disease without any signs of bladder muscle or lympho-vascular invasion, a condition known as metastatic non-m...
www.nature.com
December 3, 2024 at 10:00 AM
Reposted by Bladder Cancer
jama.com
Cervical cancer mortality in US women younger than 25 years significantly declined between 2016 and 2021, likely due to the widespread adoption of HPV vaccination.

ja.ma/4i9ghPC
November 28, 2024 at 12:37 AM
Reposted by Bladder Cancer
crisbergerot.bsky.social
Comprehensive care is🔑in #BladderCancer
Our editorial explores how exercise, nutrition & psychosocial support improve outcomes

@paulobergerot.bsky.social
& cols

Editorial acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
Paper acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
November 28, 2024 at 11:31 PM
Reposted by Bladder Cancer
sasankaatapattu.bsky.social
🦷 New Research: Higher oral health literacy linked to better quality of life in bladder cancer patients! Study of 194 patients reveals dental knowledge impacts treatment outcomes. #BladderCancer #OralHealth #CancerResearch​​​​​​​​​​​​​​​​
www.frontiersin.org/journals/pub...
Frontiers | Relationship between oral health literacy and oral health-related quality of life in patients with bladder cancer
IntroductionBladder cancer is one of the most important diseases that threatens oral and dental health due to its nature and side effects of chemotherapy. Th...
www.frontiersin.org
November 27, 2024 at 2:31 AM
Reposted by Bladder Cancer
dhsc-answers.bsky.social
A question on #BladderCancer #MedicalTreatments tabled by Ms Julie Minns on 18-11-2024 has been answered by Karin Smyth. https://questions-statements.parliament.uk/written-questions/detail/2024-11-18/14793
November 21, 2024 at 12:51 PM
Reposted by Bladder Cancer
oncoalert.bsky.social
Day One of #BLADDR24
Dr Maria De Santis
MIBC ESMO congress highlights #BladderCancer

Perioperative durvalumab to neoadj gemcitabine & cisplatin improves EFS & OS, w/o delays in radical cystectomy

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
November 27, 2024 at 9:37 AM
Reposted by Bladder Cancer
oncoalert.bsky.social
Day 1 of #BLADDR24
Dr. Petros Grivas

The concept of withholding radical treatment, such as radical cystectomy (RC) or radiotherapy, for patients with a clinical complete response (cCR) after neoadjuvant or induction systemic therapy is emerging as a potential future approach in #BladderCancer MGt
November 27, 2024 at 4:31 PM
Reposted by Bladder Cancer
aniketdeshpande.bsky.social
De-intensifying follow ups in low grade NMIBC will certainly help both patients (reduced visits) & clinicians/healthcare economy (reduced costs). However, careful patient selection is key!
#bladdercancer #NMIBC #informeddecisionmaking
November 27, 2024 at 2:52 PM
Reposted by Bladder Cancer
yukselurun.bsky.social
Perioperative Durvalumab + chemo improves event-free survival and OS in operable bladder cancer. No increase in Grade 3/4 toxicity vs chemo alone. #BladderCancer #Oncology #CancerResearch
@oncoalert.bsky.social
November 19, 2024 at 10:18 PM
Reposted by Bladder Cancer
yukselurun.bsky.social
☢️💊💉Trimodality therapy offers hope for recurrent T1 bladder cancer after BCG failure!
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
November 27, 2024 at 12:49 AM
Reposted by Bladder Cancer
icr-ctsu.bsky.social
The RAIDER findings suggest that DART is a safe and feasible option for #BladderCancer treatment, with the potential for better outcomes. www.icr.ac.uk/news-archive...
Personalised radiotherapy for people with bladder cancer shows promise
Researchers are a step closer to revolutionising how doctors use radiotherapy to treat patients with muscle-invasive bladder cancer.
www.icr.ac.uk
October 8, 2024 at 5:13 PM
Reposted by Bladder Cancer
dhsc-answers.bsky.social
A question on #BladderCancer #NewcastleUnderLyme tabled by Adam Jogee on 30-08-2024 has been answered by Karin Smyth. https://questions-statements.parliament.uk/written-questions/detail/2024-08-30/3451
September 10, 2024 at 12:10 PM
Reposted by Bladder Cancer
craiggedye.bsky.social
What a great meeting to end the week with the @anzuptrials.bsky.social Masterclass. The ANZUP community came together to brainstorm better ways to improve the outcomes of people suffering #prostatecancer and #bladdercancer. I hope my thoughts on #clinicaltrial simplification were helpful
Registrational clinical trials cost up to $4000USD per patient visit. The number of patients visits might be a function of the number of Sites x Participants x Data Points. How can we innovate to get great trials, without this massive cost? https://pmc.ncbi.nlm.nih.gov/articles/PMC7295430/ Innovations include formal Consortium collaboration and data federation models to create a true network, not perpetuating the hub-and-spoke model, transforming coordination to tele-coordination, using great educational resources like A-CTEC, the Clinical Trials Roadmap, improved graphical and simplified PICF (NationalPICF, InformedPICF), health literary editors to improve communication, partnering with consumers in priority-setting partnerships, using existing safe technologies like REDCap and MyCap, asking the best patient-focused questions, and collecting only the data you need, taking advantage of novel data collection methods like ambient AI transcription, and leveraging the movement to implement clinical quality registries in Australia to conduct pragmatic registry randomised trials, like SWEDEHEART and other great examples.
November 29, 2024 at 8:07 AM